logo

For the Inventor, By the Inventor

Nishinomiya, Japan

Katsumi Hirose

This inventor holds 8 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumi Hirose. Retrieved from https://idiyas.com/inventor/katsumi-hirose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Nishinomiya, JA (1976)
  • Kishiwada, JA (1977 - 1978)
  • Kishiwada, JP (1981)
  • Osaka, JP (1988)

Company Filing History:

goldMedal8 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1976-1988

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4775667 - Topical analgesic anti-inflammatory composition (1988-10-04),
2. 4301159 - N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives (1981-11-17),
3. 4077968 - Thiazole derivatives (1978-03-07),
4. 4025528 - Thiazole derivatives of benzoic and phenylalkanoic acids (1977-05-24),
5. 4018785 - Certain 2-iminothiazoline compounds (1977-04-19),
6. 3994908 - Substituted acetic acid derivatives and production thereof (1976-11-30),
7. 3940403 - Substituted acetic acid derivatives and production thereof (1976-02-24),
8. 3932384 - Dibenzazecines (1976-01-13),

Title: Katsumi Hirose: Innovator in Topical Analgesics

Introduction

Katsumi Hirose is a prominent inventor based in Nishinomiya, Japan. He has made significant contributions to the field of topical analgesics and anti-inflammatory compositions. With a total of 8 patents to his name, Hirose's work has had a considerable impact on medical formulations.

Latest Patents

Hirose's latest patents include a topical analgesic anti-inflammatory composition that combines a corticosteroid with conventional efficacy-proven ingredients. This innovative formulation can be embodied in various forms, such as aerosols and solutions, making it convenient for administration. The synergistic effects of the salicylate esters and L-menthol are enhanced by the addition of the corticosteroid, proving to be more effective than the individual ingredients alone. Additionally, he has developed N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives, which showcase his expertise in chemical compounds.

Career Highlights

Hirose is currently associated with Shionogi Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pain relief solutions that benefit patients worldwide.

Collaborations

Hirose has collaborated with notable colleagues, including Ryozo Maeda and Masaru Ogata, to further enhance the quality and efficacy of their innovations.

Conclusion

Katsumi Hirose's contributions to the field of topical analgesics demonstrate his commitment to improving healthcare through innovative solutions. His patents reflect a deep understanding of the complexities of pain management and anti-inflammatory treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…